[Federal Register Volume 62, Number 161 (Wednesday, August 20, 1997)]
[Notices]
[Pages 44280-44281]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-22082]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Office of the Secretary
Findings of Scientific Misconduct
AGENCY: Office of the Secretary, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: Notice is hereby given that the Office of Research Integrity
(ORI) has made a final finding of scientific misconduct in the
following case:
[[Page 44281]]
Shoushu Jiao, M.D., University of Wisconsin: Based upon reports
from the University of Wisconsin as well as information obtained by the
Office of Research Integrity (ORI) during its oversight review, ORI
found that Dr. Jiao, former Research Associate, Department of
Pediatrics, University of Wisconsin, engaged in scientific misconduct
by falsifying and creating laboratory records while conducting
biomedical research. The data in these records were reported in a
National Institute of Neurological Disorders and Stroke (NINDS),
National Institutes of Health (NIH) grant application to support a
request for Public Health Service (PHS) funding. Based on the factual
findings in the reports, the following article has been retracted:
Jiao, S., Gurevich, V., & Wolff, J.A. ``Long-term correction of rat
model of Parkinson's disease by gene therapy.'' Nature 362:450-453,
1993.
Dr. Jiao has entered into a Voluntary Exclusion Agreement with ORI
in which he has voluntarily agreed:
(1) To exclude himself from serving in any advisory capacity to
PHS, including but not limited to service on any PHS advisory
committee, board, and/or peer review committee, or as a consultant for
a period of four (4) years, beginning on August 8, 1997.
(2) To exclude himself from any contracting or subcontracting with
any agency of the United States Government and from eligibility for, or
involvement in, nonprocurement transactions (e.g., grants and
cooperative agreements) of the United States Government as defined in
45 CFR part 76 (Debarment Regulations) for a period of three (3) years,
beginning on August 8, 1997; and
(3) That any institution that submits an application for PHS
support for a research project on which Dr. Jiao's participation is
proposed, uses him in any capacity on PHS supported research, or
submits a report of PHS-funded research in which he is involved must
concurrently submit a plan for supervision of his duties to the funding
agency for approval for a period of one (1) year following the three
(3) year exclusion. The supervisory plan must be designed to ensure the
scientific integrity of Dr. Jiao's research contribution. The
institution also must submit a copy of the supervisory plan to ORI.
FOR FURTHER INFORMATION CONTACT: Acting Director, Division of Research
Investigations, Office of Research Integrity, 5515 Security Lane, Suite
700, Rockville, MD 20852, (301) 443-5330.
Chris B. Pascal,
Acting Director, Office of Research Integrity.
[FR Doc. 97-22082 Filed 8-19-97; 8:45 am]
BILLING CODE 4160-17-P
